Aurinia Pharmaceuticals (AUPH) Asset Utilization Ratio (2021 - 2026)

Aurinia Pharmaceuticals' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.4 for Q1 2026.

• Quarterly Asset Utilization Ratio fell 13.72% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (down 13.72% YoY) and the FY2025 annual result came in at 0.43, up 1.57% from the prior year.
• Asset Utilization Ratio was 0.4 for Q1 2026 at Aurinia Pharmaceuticals, down from 0.44 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.52 in Q2 2025 and bottomed at 0.13 in Q1 2022.
• A 5-year average of 0.36 and a median of 0.36 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 176.82% — and 2026, when it retreated 13.72%.
• Aurinia Pharmaceuticals' Asset Utilization Ratio stood at 0.28 in 2022, then climbed by 13.86% to 0.32 in 2023, then surged by 34.34% to 0.43 in 2024, then grew by 3.52% to 0.44 in 2025, then decreased by 8.65% to 0.4 in 2026.
• Business Quant data shows AUPH's Asset Utilization Ratio at 0.4 in Q1 2026, 0.44 in Q4 2025, and 0.52 in Q3 2025.